Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

ZimVie Inc.

ZIMVNASDAQ
Healthcare
Medical - Devices
$18.99
$0.00(0.00%)
U.S. Market is Open • 15:53

ZimVie Inc. Fundamental Analysis

ZimVie Inc. (ZIMV) shows weak financial fundamentals with a PE ratio of -27.31, profit margin of -4.39%, and ROE of -4.88%. The company generates $0.4B in annual revenue with weak year-over-year growth of -1.68%.

Key Strengths

Cash Position13.20%
PEG Ratio-19.39
Current Ratio2.37

Areas of Concern

ROE-4.88%
Operating Margin-2.05%
We analyze ZIMV's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 14.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
14.8/100

We analyze ZIMV's fundamental strength across five key dimensions:

Efficiency Score

Weak

ZIMV struggles to generate sufficient returns from assets.

ROA > 10%
-2.57%

Valuation Score

Excellent

ZIMV trades at attractive valuation levels.

PE < 25
-27.31
PEG Ratio < 2
-19.39

Growth Score

Moderate

ZIMV shows steady but slowing expansion.

Revenue Growth > 5%
-1.68%
EPS Growth > 10%
93.68%

Financial Health Score

Excellent

ZIMV maintains a strong and stable balance sheet.

Debt/Equity < 1
0.57
Current Ratio > 1
2.37

Profitability Score

Weak

ZIMV struggles to sustain strong margins.

ROE > 15%
-487.84%
Net Margin ≥ 15%
-4.39%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is ZIMV Expensive or Cheap?

P/E Ratio

ZIMV trades at -27.31 times earnings. This suggests potential undervaluation.

-27.31

PEG Ratio

When adjusting for growth, ZIMV's PEG of -19.39 indicates potential undervaluation.

-19.39

Price to Book

The market values ZimVie Inc. at 1.29 times its book value. This may indicate undervaluation.

1.29

EV/EBITDA

Enterprise value stands at 8.65 times EBITDA. This is generally considered low.

8.65

How Well Does ZIMV Make Money?

Net Profit Margin

For every $100 in sales, ZimVie Inc. keeps $-4.39 as profit after all expenses.

-4.39%

Operating Margin

Core operations generate -2.05 in profit for every $100 in revenue, before interest and taxes.

-2.05%

ROE

Management delivers $-4.88 in profit for every $100 of shareholder equity.

-4.88%

ROA

ZimVie Inc. generates $-2.57 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.57%

Following the Money - Real Cash Generation

Operating Cash Flow

ZimVie Inc. generates limited operating cash flow of $12.05M, signaling weaker underlying cash strength.

$12.05M

Free Cash Flow

ZimVie Inc. generates weak or negative free cash flow of $5.66M, restricting financial flexibility.

$5.66M

FCF Per Share

Each share generates $0.20 in free cash annually.

$0.20

FCF Yield

ZIMV converts 1.05% of its market value into free cash.

1.05%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-27.31

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-19.39

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.29

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.21

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.57

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.37

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.05

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

-0.01

vs 25 benchmark

How ZIMV Stacks Against Its Sector Peers

MetricZIMV ValueSector AveragePerformance
P/E Ratio-27.3129.43 Better (Cheaper)
ROE-4.88%800.00% Weak
Net Margin-4.39%-20145.00% (disorted) Weak
Debt/Equity0.570.30 Weak (High Leverage)
Current Ratio2.374.64 Strong Liquidity
ROA-2.57%-17936.00% (disorted) Weak

ZIMV outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews ZimVie Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-59.41%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

11.83%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-88.67%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ